Skip to content
2000
image of Pomegranate Oil Nanoemulsion as a Nanotherapeutic Strategy Against Breast and Colon Cancer: Induction of Apoptosis and Inhibition of Cell Migration

Abstract

Introduction

Cancer is increasingly recognized as a chronic condition. However, current anticancer therapies have several limitations that considerably impact patient quality of life. Therefore, we aimed to develop and characterize a pomegranate () oil-based nanoemulsion (PG-NE) with enhanced anticancer properties. We further aimed to evaluate its cytotoxic, pro-apoptotic, and anti-migratory effects on human breast (MCF-7) and colon (HCT-116) cancer cell lines.

Methods

PG-NE was formulated via high-energy emulsification and characterized by dynamic light scattering to determine droplet size, polydispersity index (PDI), and zeta potential. Its cytotoxicity was measured by the MTT assay, whereas apoptosis and migration were assessed by Annexin V/PI flow cytometry and scratch-wound-healing assays, respectively.

Results

PG-NE exhibited a mean droplet size, PDI, and zeta potential of 283.67±1.15nm, 0.17±0.01, and –35.17±0.06mV, respectively, indicating uniform nanoscale distribution and good colloidal stability. Compared with mitomycin C (MMC), PG-NE significantly decreased cancer cell viability, enhanced apoptotic induction, and strongly inhibited migration in both MCF-7 and HCT-116 cells.

Discussion

The findings indicate that nanoencapsulation enhances the anticancer efficacy of pomegranate oil by increasing its solubility and bioavailability, thereby supporting its potential as a plant-derived nanotherapeutic in integrative oncology.

Conclusion

PG-NE exhibited potent cytotoxic, pro-apoptotic, and antimigratory activities . Its physicochemical stability and biological activity support its potential use as a chemopreventive or adjunctive agent.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/acamc/10.2174/0118715206437234260120080158
2026-04-06
2026-04-17

  • From This Site

    /content/journals/acamc/10.2174/0118715206437234260120080158
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Liu B. Zhou H. Tan L. Siu K.T.H. Guan X.Y. Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduct. Target. Ther. 2024 9 1 175 10.1038/s41392‑024‑01856‑7 39013849
    [Google Scholar]
  2. Zafar A. Khatoon S. Khan M.J. Abu J. Naeem A. Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy. Discov. Oncol. 2025 16 1 607 10.1007/s12672‑025‑02198‑8 40272602
    [Google Scholar]
  3. Amirinezhadfard E. Tabar A.N. Xia L.J. Yang W.C. Plant-derived nanomaterials in cancer therapy: Advances from green synthesis to application of PANoptosis-mediated tumor suppression. Ind. Crops Prod. 2025 236 121850 10.1016/j.indcrop.2025.121850
    [Google Scholar]
  4. An Y. Sun J.X. Ma S.Y. Xu M.Y. Xu J.Z. Liu C.Q. Wang S.G. Xia Q.D. From plant-based therapy to plant-derived vesicle-like nanoparticles for cancer treatment: Past, present and future. Int. J. Nanomedicine 2025 20 3471 3491 10.2147/IJN.S499893 40125436
    [Google Scholar]
  5. Lee B.J. Kanaan M.H.G. Abdullah S.S. Ghasemian A. Plant-derived nanoparticles in cancer therapy: A comprehensive review of recent advances and future prospects. OBM Genet. 2025 9 3 1 22 10.21926/obm.genet.2503308
    [Google Scholar]
  6. Reyaz A. Qadri S.S. Javaid D. Ganie S.Y. Reshi M.S. Exploring the role of traditional medicinal plants in cancer therapy: Present efficacy and future directions. Phytomed. Plus 2025 5 3 100845 10.1016/j.phyplu.2025.100845
    [Google Scholar]
  7. Wang L. Zhu X. Liu H. Sun B. Medicine and food homology substances: A review of bioactive ingredients, pharmacological effects and applications. Food Chem. 2025 463 Pt 1 141111 10.1016/j.foodchem.2024.141111 39260169
    [Google Scholar]
  8. Singaravelan N. Tollefsbol T.O. Polyphenol-based prevention and treatment of cancer through epigenetic and combinatorial mechanisms. Nutrients 2025 17 4 616 10.3390/nu17040616 40004944
    [Google Scholar]
  9. Sadek S.A. Hoseny S.S. Soliman A.M. Fahmy S.R. Development of a novel pomegranate polysaccharide nanoemulsion formulation with anti-inflammatory, antioxidant, and antitumor properties. Curr. Drug Deliv. 2023 20 5 575 586 10.2174/1567201819666220509161548 35579149
    [Google Scholar]
  10. Baptista-Silva S. Borges S. Ramos O.L. Pintado M. Sarmento B. The progress of essential oils as potential therapeutic agents: A review. J. Essent. Oil Res. 2020 32 4 279 295 10.1080/10412905.2020.1746698
    [Google Scholar]
  11. Andreani T. Cheng R. Elbadri K. Ferro C. Menezes T. dos Santos M.R. Pereira C.M. Santos H.A. Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges. Drug Deliv. Transl. Res. 2024 14 10 2845 2916 10.1007/s13346‑024‑01649‑z 39003425
    [Google Scholar]
  12. Aljadani M. Nanotechnology-based therapeutic strategies for breast cancer. Int. J. Pharm. Investig. 2022 12 2 145 150 10.5530/ijpi.2022.2.27
    [Google Scholar]
  13. Mohamed H.R.H. Tulbah F.S.A. El-ghor A.A. Eissa S.M. Suppression of tumor growth and apoptosis induction by pomegranate seed nano-emulsion in mice bearing solid Ehrlich carcinoma cells. Sci. Rep. 2023 13 1 5525 10.1038/s41598‑023‑32488‑6 37016062
    [Google Scholar]
  14. Mohsen S. Bakr M.M. ElDegwy M.A. Abouhussein D.M.N. Fares A.R. ElMeshad A.N. Pomegranate extract-loaded surfactant-free zein nanoparticles as a promising green approach for hepatic cancer: Optimization and in vitro cytotoxicity. Future J. Pharm. Sci. 2024 10 1 73 10.1186/s43094‑024‑00647‑9
    [Google Scholar]
  15. Alkhatib M.H. Alghamdi R.S. Balamash K.S. Khojah S.M. Cinnamon oil nanoemulsion as a novel nanocarrier for bleomycin amplifies its apoptotic effect on SKOV-3 ovarian cancer cells. Indian J. Exp. Biol. 2022 59 10 697 704 10.56042/ijeb.v59i10.55777
    [Google Scholar]
  16. Choi S.J. McClements D.J. Nanoemulsions as delivery systems for lipophilic nutraceuticals: Strategies for improving their formulation, stability, functionality and bioavailability. Food Sci. Biotechnol. 2020 29 2 149 168 10.1007/s10068‑019‑00731‑4 32064124
    [Google Scholar]
  17. Wang J. Sun M. Yu J. Wang J. Cui Q. Pomegranate seeds: A comprehensive review of traditional uses, chemical composition, and pharmacological properties. Front. Pharmacol. 2024 15 1401826 10.3389/fphar.2024.1401826 39055489
    [Google Scholar]
  18. Cheng J. Li J. Xiong R.G. Wu S.X. Huang S.Y. Zhou D.D. Saimaiti A. Shang A. Feng Y. Gan R.Y. Li H.B. Bioactive compounds and health benefits of pomegranate: An updated narrative review. Food Biosci. 2023 53 102629 10.1016/j.fbio.2023.102629
    [Google Scholar]
  19. Zare M. Shaverdi H. Ebrahimi Vosta Kalaee S. Anti-cancer effects of pomegranate seed oil on esophageal cancer cell line (KYSE-30). Gene Cell Tissue 2021 8 1 e108995 10.5812/gct.108995
    [Google Scholar]
  20. Ahmadiankia N. Molecular targets of pomegranate (Punica granatum) in preventing cancer metastasis. Iran. J. Basic Med. Sci. 2019 22 9 977 988 10.22038/ijbms.2019.34653.8217 31807240
    [Google Scholar]
  21. Shetty A. Dubey A. Rodrigues V.P. Kamath S. Fernandes L. Mahadev M. Jain P. Hebbar S. Nutritional and pharmacological significance of pomegranate (Punica granatum L): A comprehensive narrative review. Nutr. Rev. 2025 nuaf165 10.1093/nutrit/nuaf165 40925043
    [Google Scholar]
  22. Khan A.A. Alanazi A.M. Alsaif N. Wani T.A. Bhat M.A. Pomegranate peel-induced silver nanoparticles and their multifaceted potential against pathogens and cancer. Saudi J. Biol. Sci. 2021 28 8 4191 4200 10.1016/j.sjbs.2021.06.022 34354399
    [Google Scholar]
  23. Zhou H. Qin D. Vu G. McClements D.J. Impact of operating parameters on nanoemulsion production using a high-pressure homogenizer with flow pattern and back-pressure control. Colloid Interfac 2023 7 1 21 10.3390/colloids7010021
    [Google Scholar]
  24. Alkhatib M.H. Aljadani M.A. Mahassni S.H. Carrying epirubicin on nanoemulsion containing algae and cinnamon oils augments its apoptotic and anti-invasion effects on human colon cancer cells. Am. J. Transl. Res. 2020 12 6 2463 2472 32655784
    [Google Scholar]
  25. Justus C.R. Marie M.A. Sanderlin E.J. Yang L.V. Transwell in vitro cell migration and invasion assays. Methods Mol. Biol. 2023 2644 349 359 10.1007/978‑1‑0716‑3052‑5_22 37142933
    [Google Scholar]
  26. Jacob S. Kather F.S. Boddu S.H.S. Shah J. Nair A.B. Innovations in nanoemulsion technology: Enhancing drug delivery for oral, parenteral, and ophthalmic applications. Pharmaceutics 2024 16 10 1333 10.3390/pharmaceutics16101333 39458662
    [Google Scholar]
  27. Kupikowska-Stobba B. Domagała J. Kasprzak M.M. Critical review of techniques for food emulsion characterization. Appl. Sci. 2024 14 3 1069 10.3390/app14031069
    [Google Scholar]
  28. Czerniel J. Gostyńska A. Jańczak J. Stawny M. A critical review of the novelties in the development of intravenous nanoemulsions. Eur. J. Pharm. Biopharm. 2023 191 36 56 10.1016/j.ejpb.2023.08.009 37586663
    [Google Scholar]
  29. Mushtaq A. Wani M.S. Malik A.R. Gull A. Ramniwas S. Ahmad Nayik G. Ercisli S. Marc A.R. Ullah R. Bari A. Recent insights into Nanoemulsions: Their preparation, properties and applications. Food Chem. X 2023 18 100684 10.1016/j.fochx.2023.100684 37131847
    [Google Scholar]
  30. Mall J. Naseem N. Haider M.F. Rahman M.A. Khan S. Siddiqui S.N. Nanostructured lipid carriers as a drug delivery system: A comprehensive review with therapeutic applications. Intelligent Pharmacy 2025 3 4 243 255 10.1016/j.ipha.2024.09.005
    [Google Scholar]
  31. Németh Z. Csóka I. Semnani Jazani R. Sipos B. Haspel H. Kozma G. Kónya Z. Dobó D.G. Quality-by-design-driven zeta potential optimisation study of liposomes with charge-imparting membrane additives. Pharmaceutics 2022 14 9 1798 10.3390/pharmaceutics14091798 36145546
    [Google Scholar]
  32. Toscano F. Torres-Arias M. Nanoparticles cellular uptake, trafficking, activation, toxicity and in vitro evaluation. Curr. Res. Immunol. 2023 4 100073 10.1016/j.crimmu.2023.100073 38020531
    [Google Scholar]
  33. Rauf A. Olatunde A. Akram Z. Hemeg H.A. Aljohani A.S.M. Al Abdulmonem W. Khalid A. Khalil A.A. Islam M.R. Thiruvengadam R. Kim S.H. Thiruvengadam M. The role of pomegranate (Punica granatum) in cancer prevention and treatment: Modulating signaling pathways from inflammation to metastasis. Food Sci. Nutr. 2025 13 2 e4674 10.1002/fsn3.4674 39898127
    [Google Scholar]
  34. Moga M.A. Dimienescu O.G. Bălan A. Dima L. Toma S.I. Bîgiu N.F. Blidaru A. Pharmacological and therapeutic properties of Punica granatum phytochemicals: Possible roles in breast cancer. Molecules 2021 26 4 1054 10.3390/molecules26041054 33671442
    [Google Scholar]
  35. Khan I. Saeed K. Khan I. Nanoparticles: Properties, applications and toxicities. Arab. J. Chem. 2019 12 7 908 931 10.1016/j.arabjc.2017.05.011
    [Google Scholar]
  36. Aljadani M.A. Alkhatib M.H. Mahassni S.H. Evaluation of proliferation and invasion of hepatocellular carcinoma cells treated with epirubicin in nanoemulsion containing natural oils. Asian J. Pharm. 2020 14 1 139 10.22377/ajp.v14i1.3578
    [Google Scholar]
  37. Zeng L. Liu X. Geng C. Gao X. Liu L. Ferroptosis in cancer. [Review] Oncol. Lett. 2024 28 1 304 10.3892/ol.2024.14437 38774452
    [Google Scholar]
  38. Mao C. Liu Y. Li X. Zhang W. Chen Y. Metabolic cell death in cancer: Ferroptosis, cuproptosis, disulfidptosis, lysozincrosis, and alkaliptosis. Protein Cell 2024 15 9 642 660 10.1093/procel/pwae003 38428031
    [Google Scholar]
  39. Hu J. Zhu J. Chen T. Zhao Y. Xu Q. Wang Y. Cuproptosis in cancer therapy: Mechanisms, therapeutic application and future prospects. J. Mater. Chem. B Mater. Biol. Med. 2024 12 47 12191 12206 10.1039/D4TB01877J 39526989
    [Google Scholar]
  40. Wan S. Liang C. Wu C. Wang S. Wang J. Xu L. Zhang X. Hou Y. Xia Y. Xu L. Huang X. Disulfidptosis in tumor progression. Cell Death Discov. 2025 11 1 205 10.1038/s41420‑025‑02495‑9 40295497
    [Google Scholar]
  41. Cui K. Wang K. Huang Z. Ferroptosis and the tumor microenvironment. J. Exp. Clin. Cancer Res. 2024 43 1 315 10.1186/s13046‑024‑03235‑0 39614322
    [Google Scholar]
  42. Thalappil M.A. Singh P. Carcereri de Prati A. Sahoo S.K. Mariotto S. Butturini E. Essential oils and their nanoformulations for breast cancer therapy. Phytother. Res. 2024 38 2 556 591 10.1002/ptr.8054 37919622
    [Google Scholar]
  43. Rahman M.A. Jalouli M. Bhajan S.K. Al-Zharani M. Harrath A.H. A comprehensive review of nanoparticle-based drug delivery for modulating PI3K/AKT/mTOR-mediated autophagy in cancer. Int. J. Mol. Sci. 2025 26 5 1868 10.3390/ijms26051868 40076496
    [Google Scholar]
  44. Bahar M.E. Kim H.J. Kim D.R. Targeting the RAS/RAF/MAPK pathway for cancer therapy: From mechanism to clinical studies. Signal Transduct. Target. Ther. 2023 8 1 455 10.1038/s41392‑023‑01705‑z 38105263
    [Google Scholar]
  45. Austria E. Bilek M. Varamini P. Akhavan B. Breaking biological barriers: Engineering polymeric nanoparticles for cancer therapy. Nano Today 2025 60 102552 10.1016/j.nantod.2024.102552
    [Google Scholar]
  46. Islam S. Ahmed M.M.S. Islam M.A. Hossain N. Chowdhury M.A. Advances in nanoparticles in targeted drug delivery – A review. Res. Surf Interf 2025 19 100529 10.1016/j.rsurfi.2025.100529
    [Google Scholar]
  47. Xiao X. Teng F. Shi C. Chen J. Wu S. Wang B. Meng X. Essiet Imeh A. Li W. Polymeric nanoparticles - Promising carriers for cancer therapy. Front. Bioeng. Biotechnol. 2022 10 1024143 10.3389/fbioe.2022.1024143 36277396
    [Google Scholar]
  48. Hong L. Li W. Li Y. Yin S. Nanoparticle-based drug delivery systems targeting cancer cell surfaces. RSC Advances 2023 13 31 21365 21382 10.1039/D3RA02969G 37465582
    [Google Scholar]
  49. Zhang P. Xiao Y. Sun X. Lin X. Koo S. Yaremenko A.V. Qin D. Kong N. Farokhzad O.C. Tao W. Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects. Med 2023 4 3 147 167 10.1016/j.medj.2022.12.001 36549297
    [Google Scholar]
  50. Liu Y. Zhang Y. Li H. Hu T.Y. Recent advances in the bench-to-bedside translation of cancer nanomedicines. Acta Pharm. Sin. B 2025 15 1 97 122 10.1016/j.apsb.2024.12.007 40041906
    [Google Scholar]
  51. Izadiyan Z. Webster T. Kia P. Kalantari K. Misran M. Rasouli E. Maghareh Esfahan Z. Shameli K. Nanoemulsions-based therapeutic strategies: Enhancing targeted drug delivery against breast cancer cells. Int. J. Nanomedicine 2025 20 6133 6162 10.2147/IJN.S488545 40385492
    [Google Scholar]
  52. Elayaperumal S. Sivamani Y. Agarwal P. Srivastava N. Plant-based nanotherapeutics: A new frontier in disease management and prevention. Nano TransMed 2025 4 100086 10.1016/j.ntm.2025.100086
    [Google Scholar]
  53. Santos D.S. Morais J.A.V. Vanderlei Í.A.C. Santos A.S. Azevedo R.B. Muehlmann L.A. Júnior O.R.P. Mortari M.R. da Silva J.R. da Silva S.W. Longo J.P.F. Oral delivery of fish oil in oil-in-water nanoemulsion: Development, colloidal stability and modulatory effect on in vivo inflammatory induction in mice. Biomed. Pharmacother. 2021 133 110980 10.1016/j.biopha.2020.110980 33249282
    [Google Scholar]
/content/journals/acamc/10.2174/0118715206437234260120080158
Loading
Pomegranate Oil Nanoemulsion as a Nanotherapeutic Strategy Against Breast and Colon Cancer: Induction of Apoptosis and Inhibition of Cell Migration
Bentham Science Publishers ; https://doi.org/10.2174/0118715206437234260120080158
/content/journals/acamc/10.2174/0118715206437234260120080158
/content/journals/acamc/10.2174/0118715206437234260120080158
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: nanoemulsion ; apoptosis ; cytotoxicity ; cancer therapy ; migration ; Pomegranate oil

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test